Related Experiment Video
Updated: Jul 14, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Bioinformatics approach to identify the hub gene associated with COVID-19 and idiopathic pulmonary fibrosis
Wenchao Shi1, Tinghui Li2, Huiwen Li3
1Department of Respiration, The Fourth Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, Heilongjiang, China.
Insights
This study identifies six genes, including S100A8, linked to severe COVID-19 and pulmonary fibrosis. A predictive model using these genes aids in assessing patient prognosis and suggests therapeutic targets.
Area of Science:
- Bioinformatics
- Genomics
- Pulmonary Medicine
Background:
- Coronavirus disease 2019 (COVID-19) is a global health crisis.
- Pulmonary fibrosis is a significant complication of SARS-CoV-2 infection.
- Understanding COVID-19's long-term effects like pulmonary fibrosis is crucial.
Purpose of the Study:
- To identify key genes associated with pulmonary fibrosis in severe COVID-19 patients.
- To develop a predictive model for assessing prognosis in SARS-CoV-2 infected individuals.
- To explore potential therapeutic targets for COVID-19-related pulmonary fibrosis.
Main Methods:
- Utilized Gene Expression Omnibus datasets for COVID-19 and idiopathic pulmonary fibrosis.
- Employed the Random Forest algorithm to screen for hub genes based on disease severity.
- Developed and validated a risk prediction model using a neural network approach.
Main Results:
- Identified six candidate genes (NELL2, GPR183, S100A8, ALPL, CD177, IL1R2) potentially involved in pulmonary fibrosis development in severe COVID-19.
- Highlighted S100A8 as a key gene strongly associated with both COVID-19 and pulmonary fibrosis.
- Successfully constructed a neural network model for predicting COVID-19 patient prognosis.
Conclusions:
- Bioinformatic analysis can identify predictive biomarkers for COVID-19 complications.
- The identified genes offer potential targets for diagnosing and treating COVID-19-associated pulmonary fibrosis.
- This research provides insights for developing targeted therapies and vaccines.
Abstract:
The coronavirus disease 2019 (COVID-19) has developed into a global health crisis. Pulmonary fibrosis, as one of the complications of SARS-CoV-2 infection, deserves attention. As COVID-19 is a new clinical entity that is constantly evolving, and many aspects of disease are remain unknown. The datasets of COVID-19 and idiopathic pulmonary fibrosis were obtained from the Gene Expression Omnibus. The hub genes were screened out using the Random Forest (RF) algorithm depending on the severity of patients with COVID-19. A risk prediction model was developed to assess the prognosis of patients infected with SARS-CoV-2, which was evaluated by another dataset. Six genes (named NELL2, GPR183, S100A8, ALPL, CD177, and IL1R2) may be associated with the development of PF in patients with severe SARS-CoV-2 infection. S100A8 is thought to be an important target gene that is closely associated with COVID-19 and pulmonary fibrosis. Construction of a neural network model was successfully predicted the prognosis of patients with COVID-19. With the increasing availability of COVID-19 datasets, bioinformatic methods can provide possible predictive targets for the diagnosis, treatment, and prognosis of the disease and show intervention directions for the development of clinical drugs and vaccines.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

